01What Stem Cell Therapy for Degenerative Disc Disease Is
Degenerative disc disease refers to the gradual breakdown of the intervertebral discs — the cushioning structures between spinal vertebrae — leading to reduced disc height, loss of hydration, and often chronic low back pain. It's an extremely common finding on spinal imaging, though not everyone with disc degeneration experiences significant pain.
DDD is a leading contributor to chronic low back pain, a condition affecting a substantial portion of adults at some point in their lives and a major cause of disability worldwide.
Do You Know about Degenerative Disc Disease?
Intervertebral discs have very limited blood supply, particularly at their center (the nucleus pulposus), which is one reason they have poor natural healing capacity once degeneration begins — and part of why researchers have been interested in cell-based approaches to potentially support disc repair.
02Symptoms of Degenerative Disc Disease
Degenerative disc disease symptoms vary, but commonly include:
- Chronic low back pain, often worse with sitting, bending, or lifting
- Pain that improves with walking or changing positions
- Occasional flare-ups of more intense pain lasting days to weeks
- Radiating pain, numbness, or tingling into the legs if a nerve is affected
- Reduced flexibility in the lower back
03Causes of Degenerative Disc Disease
Degenerative disc disease develops from a combination of factors:
- Age-Related Wear: Discs naturally lose water content and elasticity over time, which is the primary driver of DDD.
- Repetitive Strain or Injury: Heavy lifting, repetitive twisting, or trauma can accelerate disc breakdown.
- Genetics: Family history plays a meaningful role in individual susceptibility to disc degeneration.
- Smoking: Reduces blood flow and nutrient delivery to discs, accelerating degeneration.
- Obesity: Increases mechanical load on the lumbar spine.
04How Degenerative Disc Disease Is Diagnosed
Diagnosis of degenerative disc disease typically involves:
- MRI: The primary imaging tool, showing disc height loss, dehydration (“dark disc” appearance), and any nerve involvement.
- X-rays: Can show reduced disc space and bone spurs associated with chronic degeneration.
- Clinical Correlation: Because imaging findings don't always match symptoms, doctors correlate imaging with the patient's specific pain pattern and physical exam findings.
- Discography: Occasionally used to confirm which disc level is generating pain, though its use is debated.
05How Stem Cell Therapy Is Approached as a Treatment for Degenerative Disc Disease
Current Standard of Care
Conservative treatment (physical therapy, anti-inflammatory medication, activity modification) is the first-line approach and is effective for many patients. For those who don't improve, options include epidural steroid injections, and, for select cases, surgery (spinal fusion or disc replacement).
Where Stem Cell Research Fits In
For patients with chronic low back pain due to DDD who haven't responded to conservative treatment, intradiscal MSC injection has genuine randomized, sham-controlled trial support for modest pain and function improvement, with some studies also showing increased disc water content on MRI. This is generally considered before more invasive surgical options, for appropriately selected patients.
06How It's Being Explored for Degenerative Disc Disease
A 2025 systematic review and meta-analysis of seven randomized controlled trials found MSC injection was associated with significantly greater reductions in Visual Analog Scale pain scores compared to sham/placebo in patients with chronic low back pain due to DDD, concluding the therapy appears safe and effective, offering modest improvements for patients who do not respond to conservative treatment.
The RESPINE study, a prospective, multicentre, randomized, placebo-controlled trial, evaluated allogeneic bone marrow MSC injection for chronic low back pain due to disc degeneration.
The DREAM study, a Phase IIB double-blind randomized controlled trial, evaluated autologous bone marrow-derived MSC intradiscal injection in patients with moderate-to-advanced multilevel disc degeneration.
Earlier trials by Orozco et al. and Noriega et al. reported reduced pain and disability alongside increased intervertebral disc water content on MRI following MSC injection.
07What the Degenerative Disc Disease Treatment Process Looks Like
Day 1
- Pick-up from the airport to the hospital
- Initial consultation between doctor and patient to address any questions
- Admission formalities
- Clinical examination and lab tests as prescribed by the doctor
- Supportive therapy
Day 2
- Stem cell procedure
- Supportive therapies
- Physiotherapy, as appropriate
Day 3
- Supportive therapy
- Discharge formalities
- Drop-off at the airport
Note: For admission, patients should carry valid identification (passport, PAN card, or driving license) along with hard copies of relevant medical records and prior test results.
08Delivery Techniques Used in Stem Cell Therapy for Degenerative Disc Disease
Depending on the treatment plan, stem cells may be administered using one or more of the following methods:
- Intradiscal injection (image-guided, directly into the affected disc)
09Is Stem Cell Therapy Safe for Degenerative Disc Disease?
Stem cell therapy for Degenerative Disc Disease is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Degenerative Disc Disease, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.
10Who Might Consider a Degenerative Disc Disease Discussion — and Who Should Not
May be reasonable to discuss
- A confirmed degenerative disc disease diagnosis, with the patient medically stable and not in an acute emergency
- Prior imaging, neurology, and treatment records available for review
- The injury is past its acute phase, with the patient in a stable, chronic-care stage
- Realistic expectations that any benefit would be supportive and investigational, not a cure
- Willingness to continue rehabilitation and follow-up care alongside this discussion
Generally not appropriate
- Acute or unstable neurological emergencies requiring immediate critical care
- Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
- An active, untreated malignancy that has not been cleared by an oncologist
- Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
- Unwillingness to share prior medical records or to be evaluated before proceeding
This list is general and educational — it is not a substitute for an individual medical evaluation of your case.
11What a Degenerative Disc Disease Supportive-Care Discussion Involves
A supportive-care discussion for Degenerative Disc Disease isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:
- Record review: Your existing diagnosis, imaging, lab work, and treatment history for Degenerative Disc Disease are reviewed by the medical team first.
- Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
- Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
- Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
- Ongoing standard care continues: At every stage, your prescribed treatment for Degenerative Disc Disease continues unless your own treating specialist changes it.
Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.
12Our Approach to Degenerative Disc Disease Care
We recommend intradiscal MSC injection only for patients with a confirmed diagnosis of disc-related chronic low back pain who have tried and not fully benefited from conservative treatment, consistent with how the supporting clinical trials were designed and who they enrolled.
13Cost and How Stem Cell Therapy Compares for Degenerative Disc Disease
Cost varies by patient based on medical history, the number of sessions recommended, and diagnostic requirements. Because stem cell therapy is offered outside standard insurance-covered pathways in most countries, patients are encouraged to request a personalized quote and to independently verify what is and is not included (consultation, cell processing, hospital stay, and follow-up).
14Why Degenerative Disc Disease Patients Consider Treatment in India
Considerations for patients weighing this option:
- Genuine Multi-Trial RCT Evidence: One of the stronger evidence bases among chronic pain conditions covered on this site.
- Minimally Invasive: Delivered by image-guided injection, avoiding the risks of spinal fusion surgery.
- Possible Structural Benefit: Some studies report increased disc water content, suggesting more than just symptom masking.
- Modest, Not Dramatic, Effect Size: Patients should have realistic expectations about the degree of improvement.
15Quality Control in Cell Processing for Degenerative Disc Disease Therapy
Stem Cell Care India applies standard laboratory safety and screening protocols to cell processing, including infectious disease screening, microbial contamination testing, and endotoxin testing, before any cell product is cleared for use. Patients are encouraged to ask for documentation of these safety checks and of the qualifications of the treating medical team.
16What Degenerative Disc Disease Patients May Notice After Treatment
Brain injuries can range from mild to severe, and outcomes after any treatment tend to reflect that range. The idea behind exploring stem cell approaches in this context is to support the brain's own capacity to begin repairing itself, in the hope of helping patients regain functions that might otherwise remain out of reach — though this is discussed as a possible supportive step, not a guaranteed one. Reported experiences following stem cell therapy for degenerative disc disease vary from patient to patient and depend on factors such as age and injury severity. Changes some patients have reported include:
- Signs of repair in previously damaged brain tissue on follow-up assessment
- Reduced swelling or inflammation
- Changes in memory or thinking skills
- Changes in movement, balance, or coordination
- Changes in speech and communication
- General alertness and activity levels
- Support for the growth of new, healthy cells
- A generally faster pace of the body's own natural healing
Stem cell therapy is not positioned as a permanent cure for degenerative disc disease, and any benefit may take time to appear or may not appear at all. It is generally discussed as a complement to, not a replacement for, other supportive therapies.
17Quality Certification for Degenerative Disc Disease Therapy
A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.
The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Degenerative Disc Disease, and a supporting team of medical staff is described as being available throughout the process.
18Degenerative Disc Disease Follow-Up Care
Patients are typically followed with repeat pain and disability scoring (VAS, Oswestry Disability Index) and periodic MRI to assess disc hydration and structure over 6-12+ months.
19Supportive Therapies Sometimes Used Alongside Degenerative Disc Disease Treatment
Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for degenerative disc disease include:
- Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a degenerative disc disease.
- Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
- Physiotherapy: To help rebuild movement, balance, and muscle strength.
- Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
- Acupuncture: Used by some patients as a complementary approach alongside conventional care.
- Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
- Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
- Nutrition therapy: Dietary guidance intended to support general recovery.
- Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.
Any combination of these should be planned together with the treating medical team rather than pursued independently.
20Why Some International Degenerative Disc Disease Patients Consider India
Patients travel to India from the USA, UK, Europe, the Gulf region, and elsewhere for a range of medical treatments, often citing cost and access to specialized centers as key factors.
What Brings International Patients to Choose India for Medical Treatments?
- Specialized Centers: Hospitals maintain dedicated regenerative medicine departments with laboratory facilities.
- Medical Visa Assistance: Support with medical visas and required travel documentation.
- Airport Pickup and Drop: Airport transfer services on arrival and departure.
- Multilingual Support: Interpreters and translators to support non-English-speaking patients.
- Accommodation Support: In-house stays, guest houses, or hotel partnerships for comfortable lodging.
- Cost: Generally lower than equivalent private care in the US, UK, or Western Europe, though patients should request itemized quotes.
21Selected Degenerative Disc Disease Research & Publications
Verified, publicly available research relevant to this topic includes:
- Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials. (Seven RCTs; significant reduction in VAS pain scores vs. sham/placebo.)
- Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo-controlled trial (RESPINE study).
- Vadalà G, et al. Intradiscal Mesenchymal Stromal Cell Therapy for the Treatment of Low Back Pain Due to Moderate-to-Advanced Multilevel Disc Degeneration: A Preliminary Report of a Phase IIB RCT (DREAM Study). JOR Spine, 2025.
- Xie B, et al. Clinical Efficacy and Safety of Human Mesenchymal Stem Cell Therapy for Degenerative Disc Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2021)
Readers should treat any additional named studies, institutions, or statistics cited elsewhere on this topic with caution unless they can be verified through PubMed, ClinicalTrials.gov, or the original journal.
22Conclusion: Stem Cell Therapy for Degenerative Disc Disease
Degenerative disc disease is a leading cause of chronic low back pain, and it's genuinely encouraging that this is one of the more rigorously studied conditions for stem cell therapy, with multiple sham-controlled randomized trials showing modest but real benefit.
Patients considering this option should have realistic expectations — meaningful but modest improvement, not a guaranteed cure — and should generally have tried conservative treatment first.
Treatment Disclaimer: We provide consultation, case evaluation, and patient support services in the field of regenerative medicine. This page is for informational purposes and does not constitute medical advice or a guarantee of outcome.
Not sure if this applies to your case?
Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Degenerative Disc Disease — no obligation.
- Reviewed by our in-house medical team
- Doctor-reviewed reply within 24–48 hours
- No cost and no obligation to proceed
- Your information is kept confidential
Get Your Free Evaluation
Frequently Asked Questions
Yes. A 2025 systematic review and meta-analysis of seven randomized controlled trials found intradiscal MSC injection produced statistically significant reductions in pain scores compared to sham/placebo.
Described as modest but meaningful — this is not a dramatic cure, but a measurable improvement in pain and function for appropriately selected patients.
Some trials have reported increased disc water content on MRI, suggesting a possible structural effect, though this is not consistent across all studies and more research is needed to confirm lasting structural repair.
Patients with chronic low back pain clearly linked to disc degeneration who have not adequately responded to conservative treatment such as physical therapy.
Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.
Investigational-status disclaimer. This content is for informational and educational purposes only. Stem cell therapy for Degenerative Disc Disease is considered investigational under current medical guidelines in India and is not FDA-approved. No guarantees or claims of cure are made. Results vary from patient to patient. Please consult a qualified healthcare professional before making any medical decisions.